GAO Takes Exception to Agency’s Rejection of Bid Under Buy American Act
Client Alert | 1 min read | 09.13.18
In Addison Construction Company, GAO sustained a protest challenging the Department of Energy’s (DOE) rejection as nonresponsive of a bid that sought an exception to Buy American Act (the Act) requirements without providing certain information called for by FAR 52.225-9 and 52.225-10 (the clauses relevant to the exception request). While GAO acknowledged that the protester failed to provide certain required information, GAO nonetheless held that DOE could not simply reject the bid. Instead, because the protester provided sufficient information for DOE to understand the basis for the request, and because the omission of the information provided the protestor with no competitive advantage, GAO held that DOE was required to investigate whether an exception was appropriate. While the decision appears to flip the obligation that offerors submit well-written complete proposals, the decision is limited to the Act itself and the clauses at issue, which GAO held do not “require[] an agency to reject a bid as nonresponsive” in the face of missing information. As such, protestors should take heed that this case about exceptions to the rule represents the exception, not the rule.
Contacts
Insights
Client Alert | 4 min read | 09.16.26
CMS Offers Guidance as Scrutiny Rises Over ABA Therapy in Medicaid
Between 2021 and 2025, Medicaid spending on ABA therapy grew six times faster than the number of children who received services, making it one of the fastest-growing areas of Medicaid expenditure, according to CMS. On August 4, 2026, CMS released a toolkit to help state Medicaid and CHIP agencies strengthen their programs and limit fraud, waste, and abuse tied to increased demand for ABA therapy. In 2025, Medicaid spent about $10 billion on ABA and related therapy services for children with ASD — a dramatic increase from the $2 billion spent in 2021.
Client Alert | 4 min read | 09.15.26
GAO Indicates Reasonable Conflict of Interest Investigation Must Include Inquiry of Involved Firm
Client Alert | 3 min read | 09.15.26
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

